Chiaroni, Pierre-Marie
Premat, Kévin
Shotar, Eimad
Drir, Mehdi
Trebern, Hugo
Beth, Adrien
Bonnet, Baptiste
Mathout, Jugurtha
Bonaccorsi, Raphaël
Morardet, Laetitia
Cormier, Évelyne
Chiras, Jacques
Clarençon, Frédéric https://orcid.org/0000-0002-6442-8239
Article History
Received: 31 October 2021
Revised: 8 March 2022
Accepted: 30 March 2022
First Online: 21 April 2022
Declarations
:
: The scientific guarantor of this publication is Prof. Frédéric Clarençon.
: Prof. Clarençon reports a relationship with Medtronic, Guerbet, Balt Extrusion (payment for readings; non-related to the study) and Codman Neurovascular (core lab; non-related to the study).The other authors report no conflicts of interest.
: No complex statistical methods were necessary for this paper.
: The study received approval from our local institutional review board (IRB). Patient signed consent was waived by our local IRB.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: One study subject has been previously reported by Clarençon F, Shotar E, Cormier E et al (2020) Transoral vertebroplasty for the C1 lateral mass. J NeuroIntervent Surg 12:879–885. 10.1136/neurintsurg-2020-015853.
: • retrospective• observational• performed at one institution